Literature DB >> 27881862

Rheumatoid arthritis: IL-23 assists the transition from autoimmunity to inflammatory disease.

M Teresa Villanueva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27881862     DOI： 10.1038/nrrheum.2016.197

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease.

Authors:  René Pfeifle; Tobias Rothe; Natacha Ipseiz; Hans U Scherer; Stephan Culemann; Ulrike Harre; Jochen A Ackermann; Martina Seefried; Arnd Kleyer; Stefan Uderhardt; Benjamin Haugg; Axel J Hueber; Patrick Daum; Gordon F Heidkamp; Changrong Ge; Sybille Böhm; Anja Lux; Wolfgang Schuh; Iryna Magorivska; Kutty S Nandakumar; Erik Lönnblom; Christoph Becker; Diana Dudziak; Manfred Wuhrer; Yoann Rombouts; Carolien A Koeleman; René Toes; Thomas H Winkler; Rikard Holmdahl; Martin Herrmann; Stephan Blüml; Falk Nimmerjahn; Georg Schett; Gerhard Krönke
Journal:  Nat Immunol       Date:  2016-11-07       Impact factor: 25.606
  1 in total
  3 in total

Review 1.  The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.

Authors:  Wida Razawy; Marjolein van Driel; Erik Lubberts
Journal:  Eur J Immunol       Date:  2018-01-15       Impact factor: 5.532

Review 2.  Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis.

Authors:  Joyce Aarts; Annemarie Boleij; Bartijn C H Pieters; Anouk L Feitsma; R J Joost van Neerven; Jean Paul Ten Klooster; Laura M'Rabet; Onno J Arntz; Marije I Koenders; Fons A J van de Loo
Journal:  Front Immunol       Date:  2021-07-28       Impact factor: 7.561

3.  Association of interleukin-2, interleukin-21 and interleukin-23 with hyperlipidemia in pediatric type 1 diabetes.

Authors:  Rehab G Khalil; Adel Abdel-Moneim; Ahmed I Yousef; Hanan Abdel-Rahman; Mohamed I Zanaty; Amr El-Sayed
Journal:  Mol Biol Rep       Date:  2021-07-30       Impact factor: 2.316
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.